文献速递脑血管病

血清神经丝轻链:缺血性卒中后神经轴索损伤的生物标志物

Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
PubMed 文献 · Neurology · 2018-09-14

研究探讨血清神经丝轻链(NfL)作为缺血性卒中后原发性和继发性神经轴索损伤生物标志物的效用及其预测临床结局的价值。采用超灵敏单分子阵列法测定健康对照(n=30)及两个独立缺血性卒中队列的血清NfL水平,结果显示患者血清NfL从入院至卒中后6个月均高于健康对照,第7天达峰值并与梗死体积相关,卒中后6个月NfL与MRI新发缺血灶及继发性神经变性相关,第7天NfL独立预测3个月改良Rankin量表评分。

要点

  • 缺血性卒中患者血清NfL从入院至卒中后6个月均高于健康对照,第7天达峰值211.2 pg/mL。
  • 第7天血清NfL与梗死体积相关(偏相关系数r=0.736,p=1.5×10⁻¹⁵)。
  • 卒中后6个月有复发缺血灶者NfL高于无新病灶者(p=0.002)。

核心结论

  • 血清NfL有望作为监测缺血性卒中后原发性和继发性神经轴索损伤及预测功能结局的生物标志物。

研究设计与样本

  • 研究采用超灵敏单分子阵列法测定健康对照(n=30)及两个独立缺血性卒中队列的血清NfL水平。
  • 队列1在入院时(n=196)、第2、3、7天(n=89)及卒中后6个月内连续采血。
  • 队列2在基线及卒中后6个月进行标准化MRI,并在6个月时横断面采血(n=95)。

主要发现

  • 缺血性卒中患者血清NfL从入院至卒中后6个月均高于健康对照。
  • 血清NfL第7天达峰值211.2 pg/mL(104.7-442.6,中位数[四分位距]),并与梗死体积相关(第7天偏相关系数r=0.736,p=1.5×10⁻¹⁵)。
  • 卒中后6个月,MRI上有复发缺血灶者(n=19)血清NfL高于无新病灶者(n=76,p=0.002)。
  • 卒中后6个月血清NfL与弥散张量成像MRI获得的继发性神经变性定量指标相关(r=0.361,p=0.001)。
  • 卒中后第7天血清NfL独立预测3个月改良Rankin量表评分(累积比值比2.35,95%CI 1.60-3.45;p=1.24×10⁻⁵)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the utility of serum neurofilament light chain (NfL) as a biomarker for primary and secondary neuroaxonal injury after ischemic stroke (IS) and study its value for the prediction of clinical outcome. METHODS: We used an ultrasensitive single-molecule array assay to measure serum NfL levels in healthy controls (n = 30) and 2 independent cohorts of patients with IS: (1) with serial serum sampling at hospital arrival (n = 196), at days 2, 3, and 7 (n = 89), and up to 6 months post stroke; and (2) with standardized MRI at baseline and at 6 months post stroke, and with cross-sectional serum sampling at 6 months (n = 95). We determined the temporal profile of serum NfL levels, their association with imaging markers of neuroaxonal injury, and with clinical outcome. RESULTS: Patients with IS had higher serum NfL levels compared with healthy controls starting from admission until 6 months post stroke. Serum NfL levels peaked at day 7 (211.2 pg/mL [104.7-442.6], median [IQR]) and correlated with infarct volumes (day 7: partial r = 0.736, p = 1.5 × 10-15). Six months post stroke, patients with recurrent ischemic lesions on MRI (n = 19) had higher serum NfL levels compared to those without new lesions (n = 76, p = 0.002). Serum NfL levels 6 months post stroke further correlated with a quantitative measure of secondary neurodegeneration obtained from diffusion tensor imaging MRI (r = 0.361, p = 0.001). Serum NfL levels 7 days post stroke independently predicted modified Rankin Scale scores 3 months post stroke (cumulative odds ratio [95% confidence interval] = 2.35 [1.60-3.45]; p = 1.24 × 10-05). CONCLUSION: Serum NfL holds promise as a biomarker for monitoring primary and secondary neuroaxonal injury after IS and for predicting functional outcome.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tiedt S, Duering M, Barro C, et al. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke. Neurology. 2018. PMID: 30217937. doi:10.1212/WNL.0000000000006282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。